HIT advisory committees: Know data provenance, embrace standards and APIs for interoperability

The path to interoperability of health information has been a long one and will continue to be so, but healthcare organizations, IT vendors and government can take steps now to move forward on that journey, members of two federal advisory committees said this week.

In a joint meeting of the Health IT Standards Committee and Health IT Privacy Committee Tuesday, HIT Standards Committee member David McCallie Jr., MD, director of the Cerner Medical Informatics Institute, advised moving beyond a “document-centric world.” As he put it, “Don’t just move CDAs around,” referring to Health Level Seven International's Clinical Document Architecture standard.

John Halamka, MD, MS, vice chair of the HIT Standards Committee, discussed the importance of data stewardship. “Know data provenance so people can decide whether data is trustworthy,” said Halamka, CIO of Beth Israel Deaconess Medical Center in Boston.

Florida state Rep. Gayle Harrell, MA, a member of the HIT Policy Committee, reminded the panels and the public about an oft-overlooked provision of HIPAA. “Individuals have a right to access their health information,” said Harrell, a Republican from Stuart, Fla.

Harrell then was asked if HIPAA was adequate for safeguarding patient privacy to convey trust in electronic health information. “HIPAA is what we have,” she responded. “We need to advance interoperability within the framework that we have.”

Other panelists made a variety of points:

  • Consent is an ongoing process, not just individual permissions, so it makes sense to do away with standing consent forms on paper in favor of electronic queries that ask for patient consent each time new data is created.
  • There will not be a “natural arbiter” of privacy decisions.
  • One standard will not meet all needs, but federal officials and technology developers should work with as few as possible.
  • Restful application programming interfaces (APIs) will advance interoperability, which is why the Office of the National Coordinator for Health IT called for more APIs in its 10-year interoperability roadmap, published last month.

Neil Versel joined TriMed in 2015 as the digital editor of Clinical Innovation + Technology, after 11 years as a freelancer specializing in health IT, healthcare quality, hospital/physician practice management and healthcare finance.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.